Washout of small molecular contrast agent in carcinoma-derived experimental tumors

Microvascular Research

Volumn 78, Issue 3, 2009, Pages 370-378

  Galiè, Mirco ^a   Farace, Paolo ^a   Merigo, Flavia ^a   Fiorini, Silvia ^a   Tambalo, Stefano ^a   Nicolato, Elena ^a   Sbarbati, Andrea ^a   Marzola, Pasquina ^a  

^a UNIVERSITY OF VERONA   (Italy)

Author keywords

Breast carcinoma; DCE MRI; Extracellular transport; Gd DTPA; Lymphatic; Magnetic resonance imaging; Washout

Indexed keywords

CONTRAST MEDIUM; GADOLINIUM PENTETATE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BREAST CARCINOMA; CANCER DIAGNOSIS; CANCER TISSUE; CANCER TRANSPLANTATION; CONTRAST ENHANCEMENT; CONTROLLED STUDY; HISTOPATHOLOGY; HUMAN; HUMAN CELL; IMAGE ANALYSIS; IMMUNOFLUORESCENCE; IN VIVO STUDY; LYMPH VESSEL; MOUSE; NONHUMAN; NUCLEAR MAGNETIC RESONANCE IMAGING; PRIORITY JOURNAL;

ANIMALS; CONTRAST MEDIA; FEMALE; GADOLINIUM DTPA; LYMPHATIC VESSELS; MAMMARY NEOPLASMS, EXPERIMENTAL; MICE; MICE, INBRED STRAINS; MICROVESSELS; NEOPLASM TRANSPLANTATION; NEOVASCULARIZATION, PATHOLOGIC;

EID: 71549156563     PISSN: 00262862     EISSN: 10959319     Source Type: Journal    
DOI: 10.1016/j.mvr.2009.09.004     Document Type: Article

References (20)

1. Banerji S., Ni J., Wang S.X., Clasper S., Su J., Tammi R., Jones M., and Jackson D.G. LYVE-1, a new homologue of the CD44 glycoprotein, is a lymph-specific receptor for hyaluronan. J. Cell Biol. 144 (1999) 789-801
2. Bluemke D.A., Gatsonis C.A., Chen M.H., De Angelis G.A., DeBruhl N., Harms S., Heywang-Köbrunner S.H., Hylton N., Kuhl C.K., Lehman C., Pisano E.D., Causer P., Schnitt S.J., Smazal S.F., Stelling C.B., Weatherall P.T., and Schnall M.D. Magnetic resonance imaging of the breast prior to biopsy. JAMA 292 22 (2004) 2735-2742
3. Dadiani M., Margalit R., Sela N., and Degani H. High-resolution magnetic resonance imaging of disparities in the transcapillary transfer rates in orthotopically inoculated invasive breast tumors. Cancer Res. 64 (2004) 3155-3161
4. El Khoury C., Servois V., Thibault F., Tardivon A., Ollivier L., Meunier M., Allonier C., and Neuenschwander S. MR quantification of the washout changes in breast tumors under preoperative chemotherapy: feasibility and preliminary results. AJR Am. J. Roentgenol. 184 5 (2005) 1499-1504
5. Galie M., D'Onofrio M., Calderan L., Nicolato E., Amici A., Crescimanno C., Marzola P., and Sbarbati A. In vivo mapping of spontaneous mammary tumors in transgenic mice using MRI and ultrasonography. J. Magn. Reson. Imaging 19 (2004) 570-579
6. Galie M., Sorrentino C., Montani M., Micossi L., Di Carlo E., D'Antuono T., Calderan L., Marzola P., Benati D., Merigo F., Orlando F., Smorlesi A., Marchini C., Amici A., and Sbarbati A. Mammary carcinoma provides highly tumourigenic and invasive reactive stromal cells. Carcinogenesis 26 (2005) 1868-1878
7. Hassid Y., Furman-Haran E., Margalit R., Eilam R., and Degani H. Noninvasive magnetic resonance imaging of transport and interstitial fluid pressure in ectopic human lung tumors. Cancer Res. 66 (2006) 4159-4166
8. Hassid Y., Eyal E., Margalit R., Furman-Haran E., and Degani H. Non-invasive imaging of barriers to drug delivery in tumors. Microvasc. Res. 76 2 (2008) 94-103
9. Jain R.K., and Fenton B.T. Intratumoral lymphatic vessels: a case of mistaken identity or malfunction?. J. Natl. Cancer Inst. 94 (2002) 417-421
10. Kuhl C. The current status of breast MR imaging: Part I. Choice of technique, image interpretation, diagnostic accuracy, and transfer to clinical practice. Radiology 244 (2007) 356-378
11. Leu A.J., Berk D.A., Lymboussaki A., Alitalo K., and Jain R.K. Absence of functional lymphatics within a murine sarcoma: a molecular and functional evaluation. Cancer Res. 60 (2000) 4324-4327
12. Marzola P., Farace P., Calderan L., Crescimanno C., Lunati E., Nicolato E., Benati D., Degrassi A., Terron A., Klapwijk J., Pesenti E., Sbarbati A., and Osculati F. In vivo mapping of fractional plasma volume (fpv) and endothelial transfer coefficient (Kps) in solid tumors using a macromolecular contrast agent: correlation with histology and ultrastructure. Int. J. Cancer 104 (2003) 462-468
13. Partanen T.A., Alitalo K., and Miettinen M. Lack of lymphatic vascular specificity of vascular endothelial growth factor receptor 3 in 185 vascular tumors. Cancer 86 (1999) 2406-2412
14. Pathak A.P., Artemov D., Ward B.D., Jackson D.G., Neeman M., and Bhujwalla Z.M. Characterizing extravascular fluid transport of macromolecules in the tumor interstitium by magnetic resonance imaging. Cancer Res. 65 (2005) 1425-1432
15. Sherif H., Mahfouz A.E., Oellinger H., Hadijuana J., Blohmer J.U., Taupitz M., Felix R., and Hamm B. Peripheral washout sign on contrast-enhanced MR images of the breast. Radiology 205 1 (1997) 209-213
16. Szabó B.K., Aspelin P., Kristoffersen Wiberg M., Tot T., and Boné B. Invasive breast cancer: correlation of dynamic MR features with prognostic factors. Eur. Radiol. 13 11 (2003) 2425-2435
17. Teifke A., Behr O., Schmidt M., Victor A., Vomweg T.W., Thelen M., and Lehr H.A. Dynamic MR imaging of breast lesions: correlation with microvessel distribution pattern and histologic characteristics of prognosis. Radiology 239 2 (2006) 351-360
18. Thukral A., Thomasson D.M., Chow C.K., Eulate R., Wedam S.B., Gupta S.N., Wise B.J., Steinberg S.M., Liewehr D.J., Choyke P.L., and Swain S.M. Inflammatory breast cancer: dynamic contrast-enhanced MR in patients receiving bevacizumab-initial experience. Radiology 244 (2007) 727-735
19. Zeidman I., Copeland B.E., and Warren S. Experimental studies on the spread of cancer in the lymphatic system: II. Absence of a lymphatic supply in carcinoma. Cancer 8 (1955) 123-127
20. Zhao J., Salmon H., and Sarntinoranont M. Effect of heterogeneous vasculature on interstitial transport within a solid tumor. Microvasc. Res. 73 3 (2007) 224-236